27A-11206-00857
1 vaccination
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 173 / PA
- Registered
- 2021-09-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-25
Registered in v-safe
-
2021-09-25
Dose 1 — Pfizer-BioNTech
-
2021-09-25
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
-
2021-09-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Fatigue or tiredness, NauseaAdult check-in
-
2021-09-28
Survey response — days 1–6 daily, dose 1MedDRA: Sinus disorder — Feeling: Fair · Fever · NauseaFree text: Sinus problemsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-25 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Sinus problems
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Sinus disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release